Vijay Pandey

16PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyBiologically active moleculesBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 19, 2026
PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.

|Feb 21, 2025
TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma.

Shu Chen, Xi Zhang, Basappa Basappa

|Feb 07, 2025
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Chuyu He, Xuejuan Wang, Yi-Shiou Chiou

|Dec 10, 2024
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.

Shuwei Zhang, Yan Qin Tan, Xi Zhang

|Jul 27, 2024
The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer.

Tesfaye Wolde, Vipul Bhardwaj, Md Reyad-Ul-Ferdous

|Feb 28, 2024
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance.

Leiyan Yang, Miaomiao Wang, Ya Wang

Pageof 3

Frequent Collaborators

12 joint publications

Basappa Basappa

9 joint publications

Peter E Lobie

7 joint publications

Tao Zhu

7 joint publications

Zhang Xi